Mark J. Bradley’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,685
Closed -$364K 44
2022
Q4
$364K Sell
4,685
-445
-9% -$36.1K 0.32% 40
2022
Q3
$414K Sell
5,130
-15,755
-75% -$1.42M 0.38% 42
2022
Q2
$1.88M Sell
20,885
-1,610
-7% -$163K 1.7% 28
2022
Q1
$2.5M Sell
22,495
-1,820
-7% -$192K 1.78% 29
2021
Q4
$2.52M Sell
24,315
-1,830
-7% -$212K 1.64% 33
2021
Q3
$3.28M Sell
26,145
-55
-0.2% -$7.12K 2.24% 19
2021
Q2
$3.25M Sell
26,200
-1,065
-4% -$134K 2.17% 20
2021
Q1
$3.22M Buy
27,265
+950
+4% +$111K 2.18% 19
2020
Q4
$3.08M Buy
+26,315
New +$2.9M 2.12% 18

Other funds holding MDT

Mark J. Bradley's MDT Position: Q1 2023 in Review

Mark J. Bradley sold out of Medtronic (MDT) in Q1 2023, closing a stake of 4,685 shares — an estimated $364K sold.

Mark J. Bradley first reported a position in MDT in Q4 2020 and held it in 9 quarters. The position peaked at $3.28M in Q3 2021. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Mark J. Bradley reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Mark J. Bradley sold 4,685 Medtronic shares in Q1 2023, an estimated $364K.
  • Mark J. Bradley first reported a position in Medtronic in Q4 2020 and held it in 9 quarters.
  • Mark J. Bradley's Medtronic position peaked at $3.28M in Q3 2021.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Mark J. Bradley's 13F filing for Q1 2023, filed 15 May 2023.